- Biopsy Sample Fragility: Trophectoderm biopsy samples contain as few as 5–10 cells — any temperature excursion or physical trauma during transport can cause complete DNA degradation, making genetic testing impossible.
- WGA Dropout Risk: Whole Genome Amplification (WGA) failures caused by degraded template DNA produce false-positive or uninterpretable results, leading to incorrect embryo selection decisions.
- Critical Buffer Protocol: Biopsy samples must travel in validated cryogenic conditions without any exposure to ambient temperature or X-ray radiation.
- Lab-to-Lab Coordination: Successful PGT-A transport requires pre-coordination between the performing embryology lab, the certified courier, and the receiving genetics laboratory regarding packaging, media, and timing.
Why PGT-A Biopsy Samples Are Uniquely Vulnerable During Transport
Standard embryo transport involves intact blastocysts or oocytes vitrified inside cryogenic straws — robust enough to withstand the thermal stability a certified dry shipper provides. PGT-A biopsy samples are different in three critical ways:
- Minimal Cell Count: A trophectoderm biopsy typically contains between 5 and 10 cells harvested from the outer cell layer of a developing blastocyst. This is not a population — it is a collection of individual cells that, once compromised, cannot be replaced without rebiopsy (which carries its own embryo risk).
- DNA Template Sensitivity: The downstream genomic analysis — whether Next Generation Sequencing (NGS) or array Comparative Genomic Hybridization (aCGH) — depends entirely on intact double-stranded DNA template. Any nucleic acid degradation from temperature excursion produces amplification artifacts that render results uninterpretable.
- Time-Critical Coordination: Unlike frozen embryos that can remain indefinitely in cryogenic storage, biopsy samples destined for genetic labs have laboratory scheduling constraints — particularly for time-sensitive fresh cycle decisions where results are needed before a transfer window closes.
3 Critical Logistical Challenges in PGT-A Biopsy Transport
The logistical requirements that distinguish biopsy transport from standard embryo courier work fall into three categories — each capable of invalidating the genetic analysis if mishandled:
Challenge 1: Cryogenic Continuity
Biopsy samples are vitrified in labeled cryotubes. The transport container must maintain the same vapor-phase nitrogen environment used for embryo transport — any ambient temperature exposure between −80°C and room temperature triggers nucleic acid degradation within minutes. Standard dry-ice shipments are not sufficient for PGT-A samples.
Challenge 2: X-Ray Avoidance
Airport security X-ray equipment poses a specific risk to PGT-A samples. While vitrified embryos may tolerate brief radiation exposure, the DNA already extracted from cellular context in biopsy preparations is more susceptible to strand breaks. Any ionizing radiation event between biopsy and genetic analysis introduces a confounding variable — and potential liability — for the testing result.
Challenge 3: Lab Acceptance Coordination
Most genetics laboratories that perform PGT-A analysis have specific intake protocols: sample labeling formats, tube media requirements, and temperature documentation thresholds. A courier unfamiliar with the receiving lab's requirements may deliver a specimen that is immediately quarantined or rejected — delaying results and potentially missing a transfer cycle.
The Geld IVF Courier Protocol for PGT-A Biopsy Shipments
Our PGT-A transport protocol was developed in collaboration with reproductive geneticists and laboratory directors at accredited PGT testing facilities. Every biopsy shipment follows a structured procedure that addresses all three critical challenge areas:
Pre-Shipment Lab Coordination
Before pickup, our team contacts the receiving genetics laboratory to confirm their sample intake requirements, labeling specifications, and scheduling constraints. No sample leaves without a confirmed laboratory appointment and acceptance criteria on file.
Vapor-Phase Nitrogen Packaging
Biopsy samples are loaded into validated dry shippers charged with vapor-phase liquid nitrogen — the same cryogenic infrastructure used for intact embryo transport — ensuring temperature continuity from the moment the sample leaves the embryology laboratory.
X-Ray Exemption Documentation
Every courier carries pre-clearance documentation identifying the shipment as a biological substance requiring manual security inspection. X-ray screening exposure is eliminated across every transit hub on the route.
Continuous Temperature Logging
Integrated data loggers produce a complete timestamp record of internal container temperature from pickup to lab delivery — documentation that accompanies the sample for laboratory intake and patient records.
Frequently Asked Questions
-
How are PGT-A biopsy samples transported internationally?
PGT-A (trophectoderm) biopsy samples are transported in specialized cryogenic vials or tubes under strict temperature control, typically at cryogenic temperatures (−196°C) using validated dry shippers. Samples must be hand-carried to maintain continuous custody and avoid X-ray exposure, which can cause DNA strand breaks that invalidate genetic analysis results. A courier experienced with biopsy transport coordinates directly with both the biopsying clinic and the genetics laboratory.
-
Can X-rays damage DNA in PGT-A biopsy samples?
Yes. Airport security X-ray and CT scanners generate ionizing radiation that can cause DNA strand breaks in the 5–8 cells of a trophectoderm biopsy. Even low-dose radiation can lead to WGA (whole genome amplification) dropout, producing no-result or uninterpretable genetic reports. This is why certified couriers request manual inspection at every security checkpoint — never passing biopsy samples through X-ray equipment.
-
What is the difference between transporting a PGT-A biopsy and a whole embryo?
PGT-A biopsies contain 5–10 cells compared to an embryo's hundreds of cells, making them significantly more sensitive to any handling or environmental insult. The smaller cell mass means the consequences of contamination, temperature excursion, or radiation exposure are proportionally more severe — often resulting in total assay failure. DNA integrity at arrival critically determines whether a valid genetic result can be produced.
-
How long can PGT-A biopsy samples remain stable during transport?
When stored in properly filled FDA-validated dry shippers, PGT-A biopsy samples can remain stable at cryogenic temperatures for the full thermal hold period of the container — typically 10 to 27 days. Professional couriers monitor temperature continuously with data loggers throughout transit and share the complete thermal record with the receiving genetics laboratory before sample hand-off.
Genetic Results You Can Trust Begin with Transport You Can Trust
PGT-A gives families the confidence to select the chromosomally healthiest embryo for transfer. That confidence can only be earned if the biopsy sample arrives at the genetics laboratory exactly as it left the embryology lab — intact, unirradiated, and fully documented. Geld IVF Courier guarantees that chain of integrity from lab bench to genetic analysis.
Request a Quote
